Motor function in young and aged hemiplegic rats: Effects of a Ginkgo biloba extract

Neurobiology of Aging

Volumn 18, Issue 2, 1997, Pages 219-227

  Brailowsky, Simón ^a,b   Montiel, T ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

Beam test; Brain injury; Coordinated walking; Dose regimes; GFAP; Hemiplegia; Plasticity; Recovery; Treatment

Indexed keywords

GINKGO BILOBA EXTRACT; GLIAL FIBRILLARY ACIDIC PROTEIN;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HEMIPLEGIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOTOR PERFORMANCE; NERVE CELL PLASTICITY; NEUROMODULATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TASK PERFORMANCE; WALKING;

AGING; ANIMALS; BRAIN; GINKGO BILOBA; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMIPLEGIA; IMMUNOHISTOCHEMISTRY; MALE; MOTOR CORTEX; PLANT EXTRACTS; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; SEROTONIN ANTAGONISTS;

EID: 0030786348     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(97)00007-9     Document Type: Article

References (33)

1. Allain, H.; Raoul, P.; Lieury, A.; LeCoz, F.; Gandon, J.-M.; d'Arbigny, P. Effects of two doses of Ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin. Ther. 15:549-558; 1993.
2. Attella, M. J.; Hoffman, S. W.; Stasio, M. J.; Stein, D. G. Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats. Exp. Neurol. 105:62-71; 1989.
3. Brailowsky, S. Therapeutic approaches in subjects with brain lesions. In: Stein, D. G.; Sabel, B., eds. Pharmacological approaches in the treatment of brain and spinal cord injury. New York: Raven Press; 1988:1-21.
4. Brailowsky, S.; Knight, R. T. Recovery from GABA-mediated hemiplegia in young and aged rats: Effects of catecholaminergic manipulations. Neurobiol. Aging 8:441-447; 1987.
5. Brailowsky, S.; Knight, R. T.; Blood, K.; Scabini, D. GABA-induced potentiation of cortical hemiplegia. Brain Res. 362:322-330; 1986.
6. Brailowsky, S.; Montiel, T.; Hernández-Echeagaray, E.; Flores-Hernández, J.; Hernández-Pineda, R. Effects of a Ginkgo biloba extract on two models of cortical hemiplegia in rats. Restor. Neurol. Neurosci. 3:267-274; 1991.
7. Brailowsky, S.; Montiel, T.; Medina-Ceja, L. Acceleration of functional recovery from motor cortex ablation by two Ginkgo biloba extracts in rats. Restor. Neurol. Neurosci. 8:163-168; 1995.
8. Christen, Y.; Costentin, J.; Lacour, M., eds. Effects of Ginkgo biloba extract (EGb761) on the central nervous system. Advances in Ginkgo biloba extract research. Paris: Elsevier; 1992.
9. Coffey, C. E.; Wilkinson, W. E.; Parashos, I. A.; Soady, S. A.; Sullivan, R. J.; Patterson, L. J.; Figiel, G. S.; Webb, M. C.; Spritzer, C. E.; Djang, W. T. Quantitative cerebral anatomy of the aging human brain: A cross-sectional study using magnetic resonance imaging. Neurology 42:527-536; 1992.
10. De Feudis, F. V. Ginkgo biloba extract (EGb761): Pharmacological activities and clinical applications. Paris: Elsevier; 1991.
11. Dorman, D. C.; Côté, L. M.; Buck, W. B. Effects of an extract of Ginkgo biloba on bromethalin-induced cerebral lipid peroxidation and edema in the rat. Am. J. Vet. Res. 53:138-142; 1992.
12. Drieu, K. Préparation et définition de l'extrait de Ginkgo biloba. Presse Méd. 15:1455-1457; 1986.
13. Feeney, D. M.; Sutton, R. L. Pharmacotherapy for recovery of function after brain injury. CRC Crit. Rev. Neurobiol. 3:135-197; 1987.
14. Fourtillan, J. B.; Brisson, A. M.; Girault, J.; Ingrand, I.; Decourt, J. P.; Drieu, K.; Jouenne, P.; Biber, A. Pharmacokinetics of bilobalide, Ginkgolide A and Ginkgolide B in healthy volunteers following oral and intravenous administrations of Ginkgo biloba extract (EGb 761). Therapie 50:137-144; 1995.
15. Goldstein, L. B. Common drugs may influence motor recovery after stroke. Neurology 45:865-871; 1995.
16. Hofer, R. E.; Christopherson, T. J.; Scheithauer, B. W.; Milde, J. H.; Lanier, W. L. The effect of a platelet activating factor antagonist (BN-52021) on neurologic outcome and histopathology in a canine model of complete cerebral ischemia. Anesthesiology 79:347-353; 1993.
17. Hoffman, S. W.; Stein, D. G. Ginkgo biloba extract (EGb761) improves spatial performance in the Morris water maze after cortical contusion in the rat. Soc. Neurosci. Abstr. 19:1877; 1993.
18. Hoffman, S. W.; Stein, D. G. Reduction of a free radical by-product (8-isoprostane) with Ginkgo biloba extract (EGb761) treatment following cortical contusion in the rat. J. Neurotrauma 11:113; 1994.
19. Hsu, S. M.; Raine, L.; Fanger, H. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29:577-580; 1981.
20. Huguet, F.; Drieu, K.; Piriou, A. Decreased cerebral 5-HT1A receptors during ageing: Reversal by Ginkgo biloba extract (EGb 761). J. Pharm. Pharmacol. 46:316-318; 1994.
21. Huguet, F.; Tarrade, T. α2-adrenoceptor changes during cerebral ageing. The effect of Ginkgo biloba extract. J. Pharm. Pharmacol. 44:24-27; 1992.
22. Jänicke, B.; Wrobel, D. Changes in motor activity with age and the effects of pharmacologic treatment. Exp. Gerontol. 19:321-328; 1984.
23. Kaye, J. A.; DeCarli, C.; Luxenberg, J. S.; Rapoport, S. I. The significance of age-related enlargement of the cerebral ventricles in healthy men and women measured by quantitative computed X-ray tomography. J. Am. Geriatr. Soc. 40:225-231; 1992.
24. Kleijnen, J.; Knipschild, P. Ginkgo biloba. Lancet 340:1136-1139; 1992.
25. Koltringer, P.; Langsteger, W.; Eber, O. Dose-dependent hemorheological effects and microcirculatory modifications following intravenous administration of Ginkgo biloba special extract EGb 761. Clin. Hemorheol. 15:649-656; 1995.
26. Krieglstein, J.; Ausmeier, F.; Elabhar, H.; Lippert, K.; Welsch, M.; Rupalla, K.; Henrichnoack, P. Neuroprotective effects of Ginkgo biloba constituents. Eur. J. Pharmacol. Sci. 3:39-48; 1995.
27. Lacour, M.; Tighilet, B. Pharmacological activity of the Ginkgo biloba extract (EGb761) on the vestibular compensation process in the cat. Soc. Neurosci. Abstr. 19:1486; 1993.
28. Le Poncin Lafitte, M.; Rapin, J.; Rapin, J. R. Effects of Ginkgo biloba on changes induced by quantitative cerebral microembolization in rats. Arch. Int. Pharmacodyn. 243:236-244; 1980.
29. Nieto-Sampedro, M. Growth factor induction and order of events in CNS repair. In: Stein, D. G.; Sabel, B., eds. Pharmacological approaches in the treatment of brain and spinal cord injury. New York: Raven Press; 1988:301-337.
30. Oberpichler, H.; Beck, T.; Abdel-Rahman, M. M.; Bielenberg, G. W.; Krieglstein, J. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. Pharmacol. Res. Commun. 20:349-368; 1988.
31. Paxinos, G.; Watson, C. The rat brain in stereotaxic coordinates, 2nd. ed. San Diego, CA: Academic Press; 1986.
32. Petkov, V. D.; Kehayov, R.; Belcheva, S.; Konstantinova, E.; Petkov, V. V.; Getova, D.; Markovska, V. Memory effects of standardized extracts of Panax-Ginseng (G115), Ginkgo biloba (GK-501) and their combination Gincosan(R) (PHL-00701). Planta Med. 59:106-114; 1993.
33. Szabo, M.; Droylefaix, M.; Doly, M.; Braquet, P. Free radical-mediated effects in reperfusion injury: A histologic study with superoxide dismutase and EGb761 in rat retina. Ophtalmic Res. 23:225-234; 1991.